DXCM Stock-Based Compensation
Dexcom · Stock-Based Compensation
DXCM Stock-Based Compensation
Latest reported$162.40Mperiod ending
DXCM Stock-Based Comp ($0.00 → $162.40M)
Annual stock-based compensation
High-resolution chart · PNG
DXCM stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 159,600,000 | |
| 170,400,000 | |
| 150,800,000 | |
| 126,500,000 | |
| 113,400,000 | |
| 119,400,000 | |
| 102,700,000 | |
| 101,900,000 | |
| 106,200,000 | |
| 110,800,000 | |
| 82,700,000 | |
| 50,000,000 | |
| 24,600,000 | |
| 18,400,000 | |
| 13,513,000 | |
| 9,441,000 | |
| 8,366,000 | |
| 7,682,000 | |
| 6,122,000 | |
| 5,852,901,000 | |
| 1,665,572,000 | |
| 0 | |
| 0 |